亚盛医药:将在2025年美国临床肿瘤学会年会公布两项最新临床进展,其中Lisaftoclax获口头报告

动脉网
May 23

亚盛医药将在2025年美国临床肿瘤学会年会上公布APG-2575和APG-115两种药物的最新临床进展,数据显示两者均具抗肿瘤活性,支持进一步开发。其中,lisaftoclax治疗髓系恶性肿瘤的联合疗法数据首次公布,显示良好疗效。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10